Health - HealthQuill

Voyager Therapeutics, Inc., will receive an upfront payment of $100 million from Switzerland-based Novartis AG to develop gene therapies for two genetic disorders.

Novartis to pay $100m upfront to Voyager for gene therapies

HQ Team January 3, 2023: Voyager Therapeutics, Inc., will receive an upfront payment of $100 million from Switzerland-based Novartis AG to develop gene.

by HealthQuill
January 3, 2024
0 Comments

More than 50 million people in the US experience an allergic reaction every year. They are the sixth leading cause of long-term illness in that country. In India allergies are a growing concern and about 20-30% of the population suffer from at least one allergic disease.

Drugs Health Pharma

Opinion: Curb calls, use earbuds, dump old mobile phones to fight allergens

By Dr K. Leelamoni January 3, 2024: I started fretting a month ago when my friend Radhika stopped answering my cellphone calls. She.

by HealthQuill
January 3, 2024
1 Comment

After screening 12 million commercially available compounds using AI, researchers at the Massachusetts Institute of Technology have discovered a drug candidate to terminate a potentially fatal skin bacteria.

Drugs Health Pharma

MIT researchers use AI to discover new antibiotic drug compounds

HQ Team January 2, 2024: After screening 12 million commercially available compounds using AI, researchers at the Massachusetts Institute of Technology have discovered.

by HealthQuill
January 2, 2024
1 Comment

At least 521 people, including 16 health workers, have died in Gaza in attacks on hospitals and healthcare facilities over the past 36 days, according to the UN.

Health Medical Pharma

Amidst conflict, Gaza battles dual threat of disease and hunger

HQ Team January 1, 2024: As the conflict in Gaza rages on, a dual crisis emerges, with infectious diseases and hunger posing severe.

by HealthQuill
January 1, 2024
0 Comments

Drugs Health Medical

Human tears: Is it a natural antidote to male aggression?

HQ team January 1, 2024: A new study done by the Weizmann Institute of Science in Israel looks into how human female tears.

by HealthQuill
January 1, 2024
0 Comments

Smokers may benefit from Sanofi's asthma drug after a phase III trial showed "significant improvements in lung function, quality of life" and uncontrolled chronic obstructive pulmonary disease respiratory symptoms.

Drugs Health Pharma

Cytisine, an effective affordable smoking cessation aid, faces accessibility hurdles

HQ Team January 1, 2024: Smoking is injurious to health is an accepted fact by smokers even, and figures say that nine out.

by HealthQuill
January 1, 2024
0 Comments

Remember that Covid-19 is still with us, continuously evolving and forming new lineages and we still need to stay ahead of it. Maintaining a cautious vigilance rather than undue panic is the need of the day.

Drugs Health Pharma

Opinion: Covid-19 variant needs cautious vigilance, not undue panic

By K. Leelamoni The coronavirus variant JN. 1 has been causing concern among health experts and the public alike. JN.1 is surging in.

by HealthQuill
December 26, 2023
0 Comments

Bristol Myers Squibb will buy US-based biotech company, Karuna Therapeutics for $14 billion to expand its neuroscience portfolio, the companies announced.

Drugs Health Pharma

Bristol Myers to acquire Karuna Therapeutics for $14 billion

HQ Team December 23, 2023: Bristol Myers Squibb will buy US-based biotech company, Karuna Therapeutics for $14 billion to expand its neuroscience portfolio,.

by HealthQuill
December 23, 2023
0 Comments

Anglo-Swedish AstraZeneca Inc., and US-based Ionis Pharmaceuticals, announced the FDA has granted its nod for Wainua drug to treat nervous system impairment.

Drugs Health Pharma

USFDA clears AstraZeneca-Ionis’ drug for nervous system impairment

HQ Team December 22, 2023: Anglo-Swedish AstraZeneca Inc., and US-based Ionis Pharmaceuticals, announced the FDA has granted its nod for Wainua drug to.